Short Interest in Celularity Inc. (NASDAQ:CELUW) Declines By 59.4%

Celularity Inc. (NASDAQ:CELUW) was the target of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totaling 742 shares, a decrease of 59.4% from the March 15th total of 1,829 shares. Based on an average daily volume of 4,606 shares, the days-to-cover ratio is presently 0.2 days.

Celularity Stock Down 15.1%

CELUW stock opened at $0.01 on Tuesday. The company has a 50-day simple moving average of $0.01 and a 200 day simple moving average of $0.02. Celularity has a fifty-two week low of $0.01 and a fifty-two week high of $0.10.

About Celularity

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.